Cresset Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Cresset Asset Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.44M	Buy	+39,791	New	+$1.36M	0.01%	766

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Cresset Asset Management's COLL Position: Q2 2026 in Review

Cresset Asset Management opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 39,791 shares worth $1.44M. The stake represents 0.01% of the portfolio and ranks #766 among its holdings.

279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Cresset Asset Management held 39,791 shares of Collegium Pharmaceutical worth $1.44M as of Q2 2026.
Collegium Pharmaceutical was a new Cresset Asset Management position in Q2 2026.
Collegium Pharmaceutical made up 0.01% of Cresset Asset Management's portfolio in Q2 2026, its #766 holding.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.